Article

Essilor's part in KBco

Essilor of America Inc. (EOA) has acquired a majority stake in KBco, one of the leading distributors of polarized lenses in the United States. KBco will operate as an independent subsidiary of EOA.

Dallas-Essilor of America Inc. (EOA) has acquired a majority stake in KBco, one of the leading distributors of polarized lenses in the United States. KBco will operate as an independent subsidiary of EOA. Its current management team will remain in place, including Kurt Hollinger, president, and John Olsen, chief operating officer.

"This acquisition will allow Essilor to expand our presence in the polarized segment of the industry. It will enhance our portfolio of products to support our customer base," said John Carrier, president of EOA. "KBco will continue with business as usual. We will work with Kurt Hollinger, John Olsen, and their management team to leverage Essilor's strength in product research and development, distribution, marketing, and financial resources."

"We believe that this acquisition will greatly benefit our customers and employees alike," said Hollinger. "Through this acquisition, Essilor and KBco will be able to utilize the strengths of both companies to help our customers build their businesses."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
© 2025 MJH Life Sciences

All rights reserved.